Nov 1, 2022
Kent speaks with Michael Curtis, Ph.D., President & CEO of eGenesis.
Dr. Curtis has more than 30 years of experience in scientific research and leadership in biopharmaceutical drug development across multiple therapeutic areas. Before joining eGenesis he served as Chief Executive Officer, President and Head of R&D...